Norgine

Norgine is a European specialist pharmaceutical company that acquires, develops and commercialises products in gastroenterology and hepatology. Founded in 1906, the company operates across multiple European countries and maintains a global network of partnerships. It employs more than 1,400 people and reports annual net product sales of over €500 million, serving approximately 25 million patients worldwide each year.

The company's activities span the full product lifecycle: acquisition, development and commercialisation of specialist pharmaceutical products, together with licensing and partnering arrangements that include special purpose vehicles. This structure is supported by an agile infrastructure designed to accommodate flexible partnership models. Norgine's therapeutic focus is concentrated on gastroenterology and hepatology, within the wider pharmaceuticals and healthcare sector.

Norgine states three core values - Drive, Dare and Develop. Drive denotes taking ownership and delivering results; Dare refers to challenging boundaries and embracing innovation; Develop covers collaboration and mutual support for growth. The company describes a collaborative environment in which employees are empowered to make decisions and contribute to the organisation's future.